Sessions

How can we ensure that the ever-increasing amount of data in hospitals does not overload the backups, and that they can still be stored safely and without loss for many years to come?

Successful AI deployment within healthcare relies on the trust and confidence of healthcare professionals.  Based on the findings of the NHS AI lab and Health Education England report on Healthcare workers’ confidence in AI, Dr Painter explores which key factors influence confidence in healthcare AI technologies.

I denna föreläsning beskriver Pihlajalinnas Chief Medical Officer, Kaisa Kujansivu hur den disruptiva naturen hos AI har börjat påverka hela organisationen. En natur som alla vårdgivare som bestämmer sig för att nyttja AI i bred skala behöver förstå!
In this presentation, Kaisa Kujansivu, Chief Medical Officer at Pihlajalinna, describes how the disruptive nature of AI has started to affect the whole organisation. A nature that all healthcare providers who decide to use AI on a large scale must understand!

Across Europe the demand for resources in the Health sector is growing faster than the supply, and there is a growing consensus that Digital Therapeutics Apps with their ability to reach a wide part of the population at scale, and in a cost efficient way, is part of the solution.
But development of medical grade apps, that have clinical evidence and satisfy the strictest quality standards is expensive, and vendors need to know how they can be adopted and reimbursed by the healthcare system, before they develop and deploy solutions that can benefit the patients.
SelfBack is an example of one of the few medical grade apps with clinical evidence. SelfBack takes part in the EU harmonisation work of Health Technology Assessments and in this session SelfBack will share their experience from different European countries, and give an overview of how the Swedish/Nordic market access, reimbursement and regulations compares to the rest of Europe from a manufactures point of view.

Are you curious about the inner workings of biobanks and eager to learn more? Developed by EIT Health in collaboration with BBMRI-ERIC, this course is ideal for anyone interested in, studying or working in healthcare. Access our portal, you will find profiles of biobanks and health data registries from across Europe, highlighting their characteristics, specialties, and available samples or datasets. Whether you are searching for specific samples, genetic information, or other health-related data, our platform will guide you towards the relevant sources and facilitate access to these resources.

AI has been hailed as one of the instrumental changes that can help healthcare systems tackle current and future challenges. But to what extent can AI help? Milan Shah, NHS transformation specialist, talks you through a study that was conducted on a Swedish primary care health center to assess the impact of AI-enabled triage on labour productivity.

The European Health Data Space (EHDS) is an EU-wide initiative in digital health aiming at a more effective use of health data for healthcare services provision, research, innovation, policy-making and regulatory activities. While the proposal for a Regulation on the EHDS is being negotiated between the European co-legislators, there are a number of initiatives that have already been launched to prepare the ground for its rollout. In this presentation, the European Commission will give an overview of the state of play of the implementation of the EHDS.

By imposing more strict cybersecurity requirements, NIS2 aims to enhance the overall security posture of critical healthcare entities such as SaaS companies and the sensitive data they manage. This heightened focus on cybersecurity translates into increased protection for patient data, fostering trust and confidence in digital healthcare services.As SaaS companies adapt to the regulatory landscape, the resulting improvements in cybersecurity not only mitigate risks but also position these companies as trustworthy partners in the healthcare ecosystem. Patients benefit from knowing that their data is handled with the utmost care, fostering greater acceptance and utilization of digital healthcare services. Companies that proactively adapt to these changes strengthen their positions in the market, demonstrating a commitment to cybersecurity and the protection of sensitive healthcare information. Learn how to be among those that do, and how modern tools and technology cost-effectively support your security stance to live up to the requirements of NIS2.

The landscape of healthcare is rapidly evolving, with patient safety and the efficiency of patient monitoring gaining increased importance. Traditional spot-based patient surveillance methods have notable limitations, and there is substantial documentation on the benefits of more continuous monitoring approaches. Vitalthings, a Norwegian health technology company, is at the forefront of this evolution, developing contactless monitoring solutions that significantly enhance patient safety, operational efficiency, and overall cost-effectiveness. Dr. Thu will elaborate on how the continuous data harvested by this system serves as a foundation for future research and the development of AI models. This shift towards more proactive healthcare modalities, empowered by enhanced patient and staff safety, paves the way for the integration of AI into predictive medicine.

Description of the experience of setting up the French Health DataHubPresentation of progress, challenges and remaining work for the HealthData@EU pilot project

Implementing AI in healthcare safely and effectively presents a unique set of challenges. From data quality, information security, systems change, evidence generation, clinical safety and workforce transformation this session discussions the key challenges in the adoption of AI and how they might be tackled.

Our vision is to shape the future of European healthcare through the transformative power of AI. We envision a healthcare landscape where innovative AI solutions seamlessly integrate with existing systems, enabling improved patient outcomes, enhanced healthcare delivery, and equitable access to quality care. By fostering collaboration, advancing research, and facilitating market access for trustworthy AI technologies, we strive to revolutionize healthcare and empower individuals and communities to lead healthier lives.Our mission is to accelerate the development and adoption of AI solutions in healthcare by providing a cutting-edge testing and experimentation facility. We are dedicated to creating an environment that enables AI developers, researchers, and industry stakeholders to collaborate, innovate, and overcome the challenges of integrating AI into the healthcare ecosystem. Through rigorous evaluation, adherence to regulatory requirements, and a focus on ethical and societal aspects, we aim to ensure the safe, effective, and responsible use of AI in healthcare settings.

The healthcare sector often utilizes various methods to track patients' conditions, symptoms, and progress. A critical aspect of this tracking is the identification and documentation of Adverse Drug Reactions (ADRs), which include symptoms like nausea and drowsiness caused by medications. These ADRs, typically categorized by severity and frequency in databases, require medical professionals to meticulously connect them to specific drugs, a process that demands considerable expertise and time. Given the complexity of drug interactions and the limited time available for thorough investigation, this crucial area often remains under-explored. Artificial Intelligence (AI) emerges as a pivotal tool in addressing these challenges, offering decision support to doctors in pinpointing the causes of ADRs and facilitating swift and accurate drug follow-ups. This presentation will delve into a research study from a Master's Thesis project at Karolinska Institutet, exploring AI's potential in identifying rare ADR cases and aiding physicians in efficient medication management.

There is a big need for Swedish solutions to healthcare challenges around the world. What is going on within digital health in Germany, France, Spain, United Kingdom and more? Tune in to this session and learn more!  

Crafting a strategy might be difficult, but even more so to deploy and execute, especially when culture is being challenged. Successful digitalization requires a strategy update and cultural change, aligning the two. The everyday dialogue on healthcare digitalization is dominated by topics from the ¨what¨ domain, but more focus should be on the “why”, “who”, and “how” issues. Successful digitalization in the world of VUCA requires a redefined more agile and flexible leadership, mastering applied improvement science beyond “mainstream change management thinking” of today. An unmet need of today that needs to be met tomorrow.

Sector Convergence in a health tech angle is all about the transformation within the mobility and pharma industry, and how you can find solutions in areas you normally don´t expect. This is about how the industry sectors converge, how new collaborations occur and what and why AstraZeneca and Volvo Cars choose to collaborate. Come and listen to this story and be part of how innovation of tomorrow could be done.

The presentation will provide an overview of how EHDS will affect the secondary use in Sweden and EU and how the ongoing EU projects will contribute to strengthen Sweden's ability to meet the requirements of the upcoming EHDS regulation.

Medical device security is all about patient safety, a need we all recognize; it is a responsibility we all share; and it is a challenge that we need to face together.In this session, we will discuss how medical device manufacturers can support healthcare providers in securing their operating environment. We will share insight into the industry-standard ways-of-working in medical device cybersecurity. And we will explore how we can better work together to protect the safety of our patients.